Insider filing · MANE
Veradermics, Incorporated
MANE · Healthcare · 12 filings in 24 months
ticker →
Longitude Capital Partners V, LLC sold $75.2M of Veradermics (MANE)
Executed Nov 11, disclosed Nov 13, 2 days later.
Value, as filed
$75.2M
500,000 sh across 2 lots
Executed
Nov 11
the trade date, as filed
Disclosed
Nov 13
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LL
Longitude Capital Partners V, LLC
10% owner
profile →
Longitude Capital Partners V, LLC (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (1 purchase, 1 sale), most often in Veradermics, Incorporated (MANE). Across 1 priced purchase filing, the average 21-session return was +27.0% from execution and +27.0% from disclosure (delay-adjusted; derived). The largest single filing was $75.2M of MANE (500,000 sh across 2 lots, as filed), executed Nov 11.
The name
MANEHealthcare · Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthe…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Longitude Capital Partners V, LLC in MANE
MANEPURCHASE
Veradermics, Incorporated
$18.3M1,075,000 sh across 2 lots
Exec Feb 5
Filed Feb 5 · 7:03 PM ET